About us

Our educational conferences receive funding from industry, including pharmaceutical companies and MedTech industries.

Belfast conference 2026

We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference.

The sponsoring companies are Abbott, Lilly, Roche Diagnostics, Ascensia, Medtrum, Nipro and Novo Nordisk.

Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

View our sponsors page here.

UK conferences 2026

We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

View our sponsors page here.

Trend Diabetes, originally known as TREND-UK, is an award-winning organisation relaunched in 2019 to allow healthcare professionals, interested in diabetes care access to our educational resources. We now have over 21000 members from the UK and ROI.

Our resources are available in various mediums such as leaflets, in-details documents, podcasts, webinars, power point presentations and many more so take a look at www.trenddiabetes.online

Trend Diabetes is supported by a clinically active committee with expertise in practice nursing, community diabetes nursing and specialist in-patient diabetes nursing. We also have advisors from Northern Ireland, Scotland and Wales to keep us up to date with regional variations and innovations. Trend Diabetes recognises the importance of excellent physical care but also the importance of excellent psychological care for people living with diabetes, therefore, we value having access to a Psychologist advisor.

Our information leaflets are available to people with diabetes.